Filing metadata

Accession number
0000905148-24-000764
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Feb 16, 2024
Reporting period
Feb 14, 2024
Description
Insider transaction

Explore SEC Filings Hub